TY  - GEN
AU  - Schmitt-Rau,K
AU  - Rosenbach,T
AU  - Radtke,M A
AU  - Augustin,M
TI  - Cost-effectiveness of biological therapy in remission induction of moderate to severe plaque psoriasis
SN  - 1421-9832
PY  - 2011///0801
KW  - Adalimumab
KW  - Anti-Inflammatory Agents
KW  - economics
KW  - Antibodies, Monoclonal
KW  - Antibodies, Monoclonal, Humanized
KW  - Cost-Benefit Analysis
KW  - Etanercept
KW  - Germany
KW  - Health Care Costs
KW  - Humans
KW  - Immunoglobulin G
KW  - Immunologic Factors
KW  - Infliximab
KW  - Psoriasis
KW  - drug therapy
KW  - Receptors, Tumor Necrosis Factor
KW  - therapeutic use
KW  - Remission Induction
KW  - Ustekinumab
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1159/000320111
ER  -